U.S. Healthtech Stock News

Flowco Holdings (NYSE:FLOC) announced it is acquiring Valiant Artificial Lift Solutions. The deal is intended to strengthen Flowco's artificial lift capabilities and broaden its customer reach. The transaction focuses on expanding Flowco's offerings within the artificial lift solutions sector. For you as an investor, this deal sits at the core of what Flowco Holdings does, supplying artificial lift solutions to energy producers. The artificial lift space has been seeing ongoing interest as...

In February 2026, JetBlue announced it would launch twice-daily nonstop service between Houston’s George Bush Intercontinental Airport and New York’s JFK from May 21, expanding connectivity alongside its existing Houston–Boston route and offering its standard onboard amenities. This expansion reinforces JetBlue’s presence at slot-constrained JFK while giving Houston travelers wider access to its East Coast, European, Latin American, and Caribbean network. We’ll now examine how this expansion...

General Dynamics (GD) is back in the spotlight after reporting fourth quarter 2025 earnings per share of $4.17, which exceeded consensus expectations. The results were supported by strong Marine Systems performance and a reported backlog of $178.94 billion in future work. See our latest analysis for General Dynamics. On the back of the earnings beat, General Dynamics’ share price has climbed to $364.78, with a 1-day share price return of 2.17% and a 90-day share price return of 8.63%. The...

Monster Beverage has overhauled its senior leadership, naming new CEOs for its Americas and EMEA regions and appointing a Chief Strategy Officer. The changes are intended to support the company’s growth plans across global markets and sharpen execution in key regions. The leadership update comes with Monster Beverage shares trading at $81.06 under ticker NasdaqGS:MNST. For investors watching NasdaqGS:MNST, the leadership reshuffle lands after a strong multi year share price run, with the...

Wondering if American Tower is still a solid home for your capital at around US$190.20, or if the current price is leaving too much on the table for new investors? The stock has been relatively quiet over the last week with a 0.1% return. However, the 6.1% return over 30 days and 8.8% year to date contrast with a 6.1% decline over the last year and a 10.9% return over five years. These moves sit against a backdrop where American Tower continues to draw interest as a key player in listed real...

CSX (NasdaqGS:CSX) announced that its Board of Directors has approved an 8% dividend increase. The decision reflects a change in the company’s dividend policy that directly affects shareholder income. CSX is a major U.S. freight railroad operator, moving goods such as industrial products, consumer items, and agricultural commodities across its network. Railroads often play a central role in supply chains, and their financial policies can be closely watched by income focused investors. An 8%...

Churchill Downs (NasdaqGS:CHDN) has opened Marshall Yards Racing & Gaming, its eighth historical horse racing entertainment venue in Kentucky. The new property adds gaming and entertainment capacity while supporting purse funding for associated racing meets. For investors tracking Churchill Downs, the opening of Marshall Yards comes at a time when the stock trades at $93.78, with a value score of 6. Over longer periods, returns have been weak, with the share price down 18.2% over the past...

In recent months, VeriSign, Inc. has highlighted the resilience of its .COM registry monopoly, reporting ongoing revenue growth, strong free cash flow, and substantial shareholder returns through US$859 million of 2025 buybacks alongside a 5.2% dividend increase. This combination of a legally protected core franchise and consistent cash returns underscores how reliant the business model is on stable, recurring domain revenues. Against this backdrop of robust cash generation and increased...

In late February 2026, the Centers for Medicare & Medicaid Services confirmed it will assign specific C-codes for Inspire Medical Systems’ Inspire V device in an upcoming outpatient coding update, resolving longstanding reimbursement uncertainties for its hypoglossal nerve stimulation therapy for obstructive sleep apnea. This coding clarification is important because it simplifies hospital and ambulatory surgery center billing, may improve payment predictability, and could make it easier for...

Rigetti Computing (RGTI) is drawing fresh attention as its March 4 fourth quarter 2025 earnings report approaches, with investors focused on revenue, Remaining Performance Obligations, and guidance after the postponed Cepheus-1-108Q launch. See our latest analysis for Rigetti Computing. At a share price of $17.69, Rigetti has seen short term pressure, with a 90 day share price return of 25.92% decline and a year to date share price return of 25.04% decline. This comes even though the 1 year...

In late February 2026, Invesco Ltd. launched the Invesco Core Plus Real Estate Trust for defined contribution plans and four new fixed-income ETFs, while also lifting its share repurchase authorization to US$2.50 billion and declaring dividends across its closed-end fund lineup. Together with SEC approval for dual share classes and survey data showing strong participant interest in private markets, these moves highlight Invesco’s push to widen retirement access to alternatives and deepen its...

Par Pacific Holdings (NYSE:PARR) reported record refining throughput in 2025, including recovery from an earlier operational issue at its Wyoming refinery. The company recorded a substantial gain tied to an EPA small refinery exemption in 2025. Par Pacific launched the Hawaii Renewables joint venture and advanced plans for a renewable fuels facility in 2025. The company carried out a major share repurchase in 2025, highlighting a focus on shareholder returns. Par Pacific Holdings, the...

If you are wondering whether TFS Financial is offering fair value at today’s price, you are not alone. This article is designed to help you weigh what the current share price might be implying. The stock most recently closed at US$14.33, with returns of 0.8% over 7 days, 1.8% over 30 days, 5.6% year to date, 17.9% over 1 year, 31.8% over 3 years and a 2.6% decline over 5 years. Recent news around TFS Financial has focused on its position as a regional bank and its role in the broader US...

What Wyndham Hotels & Resorts stock’s recent performance tells you Wyndham Hotels & Resorts (WH) has seen mixed share performance recently, with a 1 day return of about a 1.6% decline and a 7 day move of roughly a 3.1% decline. Over the past month and past 3 months, the stock shows positive returns of about 10.6% and 10.2%, while the 1 year total return sits around a 22.7% decline, giving investors a mixed picture. See our latest analysis for Wyndham Hotels & Resorts. At a share price of...

Guidewire Software (GWRE) is back in focus after Sompo Group agreed to roll out Guidewire Cloud Platform across its global and Japanese insurance operations, while recent AI commentary has also supported sentiment around enterprise software providers. See our latest analysis for Guidewire Software. The Sompo cloud rollout and supportive AI commentary arrive after a sharp near term rebound, with a 7 day share price return of 21.92%, set against a softer 90 day share price return of 30.60%...

If you are wondering whether CBIZ at around US$28.80 is starting to look interesting, the key question is whether the market is underestimating or fairly reflecting its underlying worth. The share price has moved around recently, with a 4.0% gain over the last 7 days, set against a 26.8% decline over 30 days and a 62.5% decline over 1 year. This can change how investors view both its potential and its risk. These moves are landing in a period where investors are reacting to ongoing corporate...

Insmed reported that the US commercial launch of BRINSUPRI has exceeded internal expectations. On the back of this outperformance, the company plans to accelerate and broaden BRINSUPRI’s rollout across the US market. Insmed also intends to further grow ARIKAYCE in 2026, signaling an updated product commercialization plan beyond routine quarterly results. For investors watching Insmed (NasdaqGS:INSM), the BRINSUPRI update comes after a sharp share price move over the past year. The stock...

In February 2026, Cipher Mining Inc. changed its name to Cipher Digital Inc., reported full-year 2025 sales of US$223.94 million versus US$151.27 million a year earlier, and recorded a net loss of US$822.24 million compared with US$44.64 million previously. The rebrand and results highlight Cipher Digital’s pivot away from Bitcoin mining toward high-performance computing data centers, backed by long-term hyperscaler leases and fresh financing to support this infrastructure buildout. Next,...

If you are wondering whether Amcor's recent share price moves still leave value on the table, you are not alone. This article is aimed at helping you weigh that up clearly. Over the short term, the stock has had a 4.8% decline over 7 days, but an 8.8% return over 30 days and a 14.5% return year to date, with a 0.7% return over 1 year, 2.1% over 3 years and 3.9% over 5 years. Taken together, these figures give a mixed picture of momentum and risk sentiment. This article was prompted to keep...

In late February 2026, Delek Logistics Partners, LP reported full-year 2025 results showing revenue of US$1,013.32 million and net income of US$176.46 million, alongside record adjusted EBITDA of US$536 million and the commissioning of its Libby 2 gas processing plant. The partnership also marked its 52nd consecutive quarterly distribution increase and highlighted the growing contribution of its integrated crude, gas, and water midstream platform in the Permian Basin. We’ll now examine how...

In February 2026, Kimberly-Clark’s Kotex brand launched a fully reimagined range of pads and liners, introducing Gravity™ Core technology, a 5X System with LeakShield™, new BioCare and Bamboo lines, teen-focused and overnight products, and a bold visual identity, with nationwide US rollout across major retailers. This portfolio overhaul directly targets widespread consumer frustration with existing period products, aiming to differentiate Kotex through comfort-focused materials, odor and pH...

Five9 (FIVN) is back in focus after reporting Q4 and full year 2025 results, issuing 2026 guidance, and spotlighting enterprise AI growth that now exceeds a US$100 million annual run rate. See our latest analysis for Five9. Despite the earnings beat and fresh 2026 guidance, Five9’s recent 90 day share price return decline of 11.27% and 1 year total shareholder return decline of 49.33% suggest momentum has been under pressure, even as enterprise AI becomes a larger part of the story. If this...

Ardagh Metal Packaging (AMBP) has given investors plenty to think about after reporting 2025 results that exceeded its own guidance, outlining 2026 adjusted EBITDA growth expectations, completing a US$1.3b green bond refinancing, and affirming a quarterly dividend. See our latest analysis for Ardagh Metal Packaging. The recent earnings beat, 2026 EBITDA guidance and US$1.3b green bond refinancing sit against a share price of US$4.85, with a 30 day share price return of 10.48% and a 1 year...

Event overview and immediate context Generate Biomedicines (GENB) recently drew investor attention after a single day move of about 3.8% and a year to date return of roughly a 23.9% decline, prompting closer scrutiny of its drug discovery model and early stage pipeline. See our latest analysis for Generate Biomedicines. For now, the 1 day share price return of about 3.8% and year to date share price return of roughly a 23.9% decline suggest sentiment has cooled, even as interest in its...